Ten reasons why A1C should not be used as a screening tool for T2DM
Screening of a disease can be understood as detecting a disease in an individual before clinical symptoms are apparent. In case of diabetes mellitus, as of now, the preferred screening test is still fasting blood sugar (FBS). Glycated hemoglobin (A1C) however, did make its way into guidelines as a d...
保存先:
第一著者: | Shahar, Mohammad Arif |
---|---|
フォーマット: | Conference or Workshop Item |
言語: | English |
出版事項: |
2017
|
主題: | |
オンライン・アクセス: | http://irep.iium.edu.my/58564/1/Debate%20HbA1C.pdf http://irep.iium.edu.my/58564/ |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
類似資料
-
Evidence based guidelines. Diagnosis and management of Guillain-Barre syndrome in ten steps
著者:: Leonhard, Sonja E., 等
出版事項: (2021) -
Who should be screened for primary aldosteronism? A comprehensive review of current evidence
著者:: Huang, Wei Chieh, 等
出版事項: (2022) -
Ten years review of cancer bladder in Hospital Universiti Sains Malaysia, Kubang Kerian
著者:: Almotawakel, Ahmed Ali Abdullah
出版事項: (2006) -
What elements of sport and exercise science should primary care physicians learn? an interdisciplinary discussion
著者:: Wattanapisit, Apichai, 等
出版事項: (2021) -
TrueDx TSH assay is an acceptable screening test for both hypo- and hyperthyroidism in the general population: correlation between trueDx TSH assay and the standard 3rd Generation TSH Chemoluminiscence Immunoassay (CMIA)
著者:: Shahar, Mohammad Arif, 等
出版事項: (2017)